Stories

Meijer’s bipartisan bill would coordinate federal, multi-agency study of PFAS

U.S. Rep. Peter Meijer (R-MI) on March 30 cosponsored bipartisan legislation that would implement a federal per-and polyfluoroalkyl substances (PFAS) study to uncover the health hazards communities face when exposed to these toxic, man-made substances.

“This bill takes a meaningful step towards advancing our understanding of PFAS and identifying what more is needed to combat it,” Rep. Meijer said.

The Federal PFAS Research Evaluation Act, H.R. 7289, which is sponsored by U.S. Rep. Lizzie Fletcher (D-TX), would require federal agencies with existing PFAS research to work with the National Academies of Science to conduct a two-phase study on PFAS exposure and toxicity and to develop a federal research and development plan to address PFAS exposure, according to a bill summary provided by the lawmakers.

“We know that PFAS contaminants are harmful to our health and our environment, but with hundreds of different compounds, much remains unknown,” said Rep. Meijer. “We need an all-hands-on-deck coordinated research approach to develop a comprehensive, effective response to PFAS.”

There are more than 5,000 types of registered PFAS compounds, a chemical class that is not currently regulated at the federal level, despite being detected in air, water, soil, food, biosolids, and more, according to the text of H.R. 7289.

PFAS accumulate and remain in the body for a long time, and can lead to serious health problems, including cancer, low infant birth weight, liver and kidney issues, and reproductive and developmental problems, among others, the text says.

Within 90 days of the enactment of H.R. 7289, the administrator of the Environmental Protection Agency, in consultation with the director of the National Science Foundation, the U.S. Defense Secretary, the National Institutes of Health director, and other relevant federal agencies would be required to enter into an agreement with the National Academies to conduct the two-phase study and submit reports that identify research and development needed to advance human exposure estimation and toxicity, and hazard estimation of individual or total PFAS, according to the bill.  

“It is critical that we understand the depth of the health implications [PFAS] pose for our communities,” said Rep. Fletcher.

Ripon Advance News Service

Recent Posts

Republicans’ bill to ensure security assistance to Israel passes House

The U.S. House of Representatives on May 16 voted 224-187 to approve legislation led by…

15 hours ago

House advances Carey’s bipartisan Youth Poisoning Protection Act

A bipartisan bill cosponsored by U.S. Rep. Mike Carey (R-OH) that would ban a hazardous…

15 hours ago

House Financial Services Committee passes lending bills from Kim, Hill

Legislation led by U.S. Rep. French Hill (R-AR) to protect small banks and lenders from…

15 hours ago

EV credit rules could end under bipartisan, bicameral resolution offered by Miller, Fischer

U.S. Rep. Carol Miller (R-WV) and U.S. Sen. Deb Fischer (R-NE) on May 16 proposed…

15 hours ago

Moolenaar’s bipartisan bill to halt TB outbreaks moves to House

The U.S. House Energy and Commerce Health Subcommittee on May 16 approved a bipartisan bill…

15 hours ago

Kelly’s legislation would expand E-3 nonimmigrant visa program

U.S. Rep. Mike Kelly (R-PA) on May 14 signed on as the lead original cosponsor…

16 hours ago

This website uses cookies.